Evidence map›Paper›PMID 34926348›Full record

ArticleFrontiers in pediatrics2021

Case Report:

Nadim Cassir, Isabelle Grandvuillemin, Manon Boxberger, Priscilla Jardot, Farid Boubred, Bernard La Scola

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nadim CassirDepartment of Clinical Microbiology, Aix Marseille Université, Institut de Recherche pour le Développement, Assistance Publique des Hôpitaux de Marseille, Microbes, Evolution, Phylogénie et Infection, Marseille, France.
Isabelle GrandvuilleminDepartment of Neonatology, Hôpital La Conception, Assistance Publique des Hôpitaux de Marseille, AMU, Marseille, France.
Manon BoxbergerDepartment of Clinical Microbiology, Aix Marseille Université, Institut de Recherche pour le Développement, Assistance Publique des Hôpitaux de Marseille, Microbes, Evolution, Phylogénie et Infection, Marseille, France.
Priscilla JardotDepartment of Clinical Microbiology, Aix Marseille Université, Institut de Recherche pour le Développement, Assistance Publique des Hôpitaux de Marseille, Microbes, Evolution, Phylogénie et Infection, Marseille, France.
Farid BoubredDepartment of Neonatology, Hôpital La Conception, Assistance Publique des Hôpitaux de Marseille, AMU, Marseille, France.
Bernard La ScolaDepartment of Clinical Microbiology, Aix Marseille Université, Institut de Recherche pour le Développement, Assistance Publique des Hôpitaux de Marseille, Microbes, Evolution, Phylogénie et Infection, Marseille, France.
Aix-Marseille Université · FRAssistance Publique Hôpitaux de Marseille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Necrotizing enterocolitis is a life-threatening acquired gastrointestinal disorder among preterm neonates and is associated with a high mortality rate and long-term neurodevelopmental morbidity. No etiologic agent has been definitively established; nonetheless, the most implicated bacteria include members of the

Indexed as

case reportClostridium neonatalegut microbiotanecrotizing enterocolitispreterm neonate

Identifiers

PMID34926348
PMCPMC8674942
OpenAlexW3215778831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.